Delivery Order SPE2DB20D3303-SPE2DB25FA1XA
- Not listed
- The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 8 mg daily dose (60-count supply) with an ultimate completion date of September 2, 2025. This non-set-aside contract was competitively awarded on August 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LENVIMA (lenvatinib) is a targeted cancer therapy used in the treatment of various malignancies, reflecting the...
- The Defense Logistics Agency (DLA) awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 20 MG daily dose (60-count supply) with an ultimate completion date of August 19, 2025. This non-set-aside competitive award was issued on July 29, 2025, with performance to be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy medication, reflecting the federal government's continued reliance on...
- The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose tablets (30-count package) with an ultimate completion date of August 19, 2025. This non-competitive delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy indicated for multiple malignancies, and this award reflects...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of LENVIMA 10 mg daily dose in a 30-count package with a ceiling value of $10,223.24. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 25, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LENVIMA 18 mg daily dose tablets (90-count supply) valued at $10,223.24 under a firm fixed-price contract type. The award was made on August 8, 2025, with an ultimate completion date of August 29, 2025, and no set-aside designation was utilized. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Lenvima 8 mg daily dose tablets (60-count supply) with a completion deadline of August 20, 2025. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation, reflecting...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LENVIMA 10 MG DAILY DOSE 30S. The contract has a ceiling value of $9,910.95 and a period of performance ending on June 30, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LENVIMA 8 MG DAILY DOSE 60S, a pharmaceutical product, with a ceiling value of $9,910.95 and a period of performance through July 30, 2025. The contract is a delivery order, with a firm fixed price pricing type. It is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for the supply of Lenvima 8 mg daily dose in a quantity of 60 tablets. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made without a set-aside designation, reflecting open competition among eligible vendors. This delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LENVIMA 10 MG DAILY DOSE 30S. The contract has a ceiling value of $9,910.95 and a completion date of July 16, 2025. It is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1XADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose 30-count supply on July 29, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA (lenvatinib) is a targeted cancer therapy used to treat various malignancies, reflecting the breadth of specialized pharmaceutical products that AmerisourceBergen supplies through federal medical procurement channels. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a prime contractor, AmerisourceBergen serves as a critical pharmaceutical distributor for military and federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard, supplying an expansive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive federal contracting history demonstrates its capability to meet complex medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 7/29/25 |